Home › Interstitial Lung Diseases › Illinois
Interstitial Lung Diseases clinical trials in Illinois
12 studies for Interstitial Lung Diseases are looking for participants at sites in Illinois.
Cities in Illinois
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Chicago, Chicago
- Northwestern University, Evanston
- Loyola University Health System, Maywood
RecruitingObservational study
Ages 21 and older · All sexes · Updated Nov 12, 2026 · NCT01915511Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Northwestern University, Chicago
- University of Illinois Health, Chicago
Recruiting
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06911632RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Oct 16, 2026 · NCT06328777A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Northwestern University, Chicago
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 14, 2026 · NCT07285655Pulmonary Fibrosis Foundation Community Registry
- Pulmonary Fibrosis Foundation, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT05382572A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Chicago
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Chicago
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Northwestern University, Chicago
- Loyola University Medical Center, Maywood
- Advocate Christ Medical Center, Oak Lawn
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- The University of Chicago Medical Center (UCMC), Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05943535A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- University of Chicago, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 9, 2026 · NCT00470327Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 7, 2025 · NCT05892614From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.